Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01046123 : Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases
PhasePhase 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Age ? 18

- pathologically confirmed solid malignancy diagnosed within the past 5 years (if the
original pathological cancer diagnosis is more than 5 years earlier, a biopsy to
confirm metastatic relapse within the past 5 years is required)

- 1-10 brain metastases

- Maximum diameter of largest metastasis ? 3 cm

- KPS ? 70

- Patient is neurologically stable with or without corticosteroids

- Extracranial disease well-controlled (6-month estimated median life expectancy).

- Available for regular clinical and imaging follow up

- Prior craniotomy permitted

Exclusion Criteria:

- Require craniotomy to relieve mass effect

- Previous cranial radiotherapy

- Metastatic germinoma, small cell carcinoma, multiple myeloma, lymphoma or leukaemia.

- Chemotherapy administered within one week before radiotherapy or planned within one
week after radiotherapy.

- Metastases within 0.7 cm of the optic chiasm, brainstem or optic nerves

- Brainstem metastases

- Systemic lupus erythematosis, scleroderma, or other connective tissue disorders not
in remission

- Multiple sclerosis

- Glomerular Filtration Rate < 60 ml/minute

- Non-small cell lung cancer with liver metastases

- Bilirubin > upper normal limit

- AST or ALT > 2X upper normal limit

- Pregnancy

- Summed volume of all metastasis PTVs > 50 cm3
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557